clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
New Genetic Variants May Help Explain Why More Boys Get Autism
News & Features
Machine Learning Uncovers Osteosarcoma Subtypes, Paving the Way for Personalized Medicine
Informatics
AI Crunches Clinical Notes to Highlight Care Improvement Opportunities
News & Features
Study Suggests Cytomegalovirus Could Contribute to Alzheimer’s Pathology in Certain Individuals
News & Features
Mutated Cilia Implicated in Pathology of ALS
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Altering Proteins Can Help Limit Mucous Production in Lung Diseases
Chronic obstructive pulmonary disease
News & Features
Altering Proteins Can Help Limit Mucous Production in Lung Diseases
July 16, 2021
0
Molecular Dx
Lung-on-a-Chip Model Will Help Design New Respiratory Drugs
May 7, 2021
0
News & Features
Type of Bacteria and Abundance in Oral Microbiome Linked to Lung Cancer Risk in Nonsmokers
December 15, 2020
0
Coronavirus
Analysis Sheds Light on Biology of Serious COVID-19 Cases and Outlines Treatment Options
June 1, 2020
0
Coronavirus
Smokers, COPD Patients’ Increased Levels of ACE2 Receptors Make Them More Vulnerable to SARS-CoV-2 Infection
April 9, 2020
0
Molecular Dx
SQI Diagnostics Partners with UHN on Diagnostic for Lung Transplantation
February 5, 2019
0
News & Features
AstraZeneca to ID Asthma, COPD Biomarkers Using Owlstone Medical’s Breath Biopsy
April 9, 2018
0
1
2
3
Page 3 of 3
Related Content
Genetic Importance for Flu Vaccine Protection Could Broaden Pandemic Preparedness
Two Key Studies Add to Evidence That Certain Oils Cause Cancer
First Synovial Fluid Biomarker Test Accurately Diagnoses Primary Osteoarthritis
New Immunotherapy Platform Better Targets Cancer Cells
Inside Precision Medicine
![Owlstone Medical's Breath Biospsy platform services will be used by AstraZeneca to identify novel biomarkers differentiating between disease phenotypes for asthma and COPD. [Owlstone Medical]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1594.jpeg "AstraZeneca to ID Asthma, COPD Biomarkers Using Owlstone Medical’s Breath Biopsy")
